The first children have received the RTS,S/AS01 (RTS,S) malaria vaccine through routine immunization in Malawi, marking the beginning of a pilot introduction of the vaccine. Read more......
MVI PortfolioWe strategically use our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity.
Evaluation technology projectsWe partner to develop and optimize new assays and challenge models and support reference and service laboratories.
RTS,SRTS,S/AS01 (RTS,S) is the world’s first malaria vaccine shown to provide partial protection against malaria in young children.